Catalent and MigVax Sign Agreement to Develop an Orally Disintegrating Freeze-Dried Tablet Vaccine Against COVID-19 Read more
Biogen and Alectos Therapeutics Announce License and Collaboration Agreement for AL01811, a Novel GBA2 Inhibitor for the Potential Treatment of Parkinson’s Disease Read more
Moderna and the European Commission Agree on Amendment to COVID-19 Vaccine Supply Agreement Read more
Myovant Sciences and Pfizer Announce FDA Acceptance of Supplemental New Drug Application for MYFEMBREE Read more
Theolytics starts a £1M project in collaboration with the University of Sheffield, supported by Innovate UK to develop a novel therapy for multiple myeloma patients Read more
Cocrystal Pharma Expands Collaboration with the National Institute of Allergy and Infectious Diseases to Evaluate COVID-19 Protease Inhibitors Read more